RHEB and tuberous sclerosis: In addition, in some clinical cases of human tuberous sclerosis, changes in GAP activity of Rheb by TSC1/2 mutations is not always correlated with disease severity of patients with tuberous sclerosis13, implicated in hyperactive mTORC1-independent symptoms.